CUSIP 23954D109COMDAWNGBXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
180 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 8.84M | $82.37M | −163.9K | Reduced |
| 2 | Atlas Venture Life Science Advisors, LLC | 6.41M | $59.77M | −17.7K | Reduced |
| 3 | Vanguard Group Inc | 6.28M | $58.55M | +101.0K | Added |
| 4 | Fmr LLC | 5.72M | $53.28M |
| −4.38M |
| Reduced |
| 5 | Vestal Point Capital, LP | 5.20M | $48.46M | +2.52M | Added |
| 6 | State Street Corp | 4.29M | $39.98M | +1.05M | Added |
| 7 | Deerfield Management Company, L.P. | 3.72M | $34.70M | −982.3K | Reduced |
| 8 | Pictet Asset Management Holding SA | 2.99M | $27.87M | +617.7K | Added |
| 9 | Aigh Capital Management LLC | 1.99M | $18.57M | +471.5K | Added |
| 10 | Geode Capital Management, LLC | 1.88M | $17.50M | +116.6K | Added |
See every fund holding Day One Biopharmaceuticals I, with full quarter-over-quarter share changes.
Unlock all holders